Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Items 11-20 of 50

Page
per page
  1. Mithramycin A
    A4546 Mithramycin A
    Summary: Anticancer antibiotic
      Soluble in DMSO
  2. UNC 0224
    A4503 UNC 0224
    Summary: G9a histone methyltransferase inhibitor
      ≥48.6 mg/mL
  3. Pyridone 6
    A3741 Pyridone 6
    Target: JAK
    Summary: Pan-JAK inhibitor
      insoluble in H2O; ≥15.45 mg/mL
  4. Ruxolitinib phosphate
    A3781 Ruxolitinib phosphate
    Summary: JAK1/JAK2 inhibitor
      ≥20.2 mg/mL
  5. Nafamostat hydrochloride
    B1178 Nafamostat hydrochloride
    Summary: Synthetic serine protease inhibitor
      Soluble in DMSO
  6. OG-L002
    B1580 OG-L002
    Summary: LSD1 inhibitor,potent and specific
      insoluble in H2O; ≥22.5 mg/mL
  7. Panobinostat (LBH589)
    A8178 Panobinostat (LBH589)
     10 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL
  8. Romidepsin (FK228, depsipeptide)
    A8173 Romidepsin (FK228, depsipeptide)
     7 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC1/HDAC2 inhibitor, potent and selective
      ≥27.04 mg/mL
  9. ITF2357 (Givinostat)
    A4093 ITF2357 (Givinostat)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      ≥23.8 mg/mL
  10. Baricitinib (LY3009104, INCB028050)
    A4141 Baricitinib (LY3009104, INCB028050)
     2 Citation
    Summary: JAK1/JAK2 inhibitor,selective orally bioavailable
      insoluble in EtOH; insoluble in H2O; ≥18.57 mg/mL

Items 11-20 of 50

Page
per page